| 标题 |
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Discovery 作者:Andreas Varkaris; Ermira Pazolli; Hakan Günaydin; Qi Wang; Levi Pierce; et al 出版日期:2023-11-02 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)